Skip to main content
. 2021 Sep 7;5:PO.20.00439. doi: 10.1200/PO.20.00439

FIG 1.

FIG 1.

Efficacy of ceralasertib and olaparib in all patients enrolled in the study. A swimmer plot demonstrating time to response and duration of study treatment. CR, complete response; HGSOC, high-grade serous ovarian cancer; PR, partial response.